K. Phillips

发表

Electrophysiological assessment methodology of sensory processing dysfunction in schizophrenia and dementia of the Alzheimer type

P. Danjou, G. Viardot, D. Maurice, 2019, Neuroscience & Biobehavioral Reviews.

Targeting the Synapse in Alzheimer’s Disease

G. Gilmour, K. Phillips, H. Marston, 2019, Front. Neurosci..

Coordinated Acetylcholine Release in Prefrontal Cortex and Hippocampus Is Associated with Arousal and Reward on Distinct Timescales

John P. Lowry, Gary Gilmour, Keith G. Phillips, 2017, Cell reports.

Disrupted visual cortical plasticity in early neurodegeneration

Fabio R. Rodrigues, A. Saleem, S. Solomon, 2020 .

Plasticity in visual cortex is disrupted in a mouse model of tauopathy

Fabio R. Rodrigues, A. Saleem, S. Solomon, 2020, Communications Biology.

Electrical and Network Neuronal Properties Are Preferentially Disrupted in Dorsal, But Not Ventral, Medial Entorhinal Cortex in a Mouse Model of Tauopathy

Jonathan T. Brown, M. Goodfellow, K. Phillips, 2016, The Journal of Neuroscience.

Impaired speed encoding and grid cell periodicity in a mouse model of tauopathy

Jonathan T. Brown, K. Phillips, J. Witton, 2020, eLife.

The nicotinic α4β2 receptor selective agonist, TC-2559, increases dopamine neuronal activity in the ventral tegmental area of rat midbrain slices

E. Sher, K. Phillips, L. Broad, 2003, Neuropharmacology.

The N13 spinal component of somatosensory evoked potentials is modulated by heterotopic noxious conditioning stimulation suggesting an involvement of spinal wide dynamic range neurons

A. Mouraux, R. Treede, L. Garcia-Larrea, 2021, Neurophysiologie Clinique.

IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of huma

A. Mouraux, R. Treede, I. Tracey, 2022, Trials.

Pharmacological Probes to Validate Biomarkers for Analgesic Drug Development

A. Mouraux, R. Treede, I. Tracey, 2022, International journal of molecular sciences.

Postsynaptic Action Potentials Are Required for Nitric-Oxide-Dependent Long-Term Potentiation in CA1 Neurons of Adult GluR1 Knock-Out and Wild-Type Mice

K. Fox, N. Hardingham, K. Phillips, 2008, The Journal of Neuroscience.

Neural oscillations as a translational tool in schizophrenia research: Rationale, paradigms and challenges

P. Uhlhaas, K. Phillips, 2015, Journal of psychopharmacology.

Partial agonists for α4β2 nicotinic receptors stimulate dopaminergic neuron firing with relatively enhanced maximal effects

K. Phillips, L. Broad, Ying Chen, 2012, British journal of pharmacology.

Differential effects of NMDA antagonists on high frequency and gamma EEG oscillations in a neurodevelopmental model of schizophrenia

Matt W. Jones, M. O'Neill, M. Tricklebank, 2012, Neuropharmacology.

Evaluating the association of TRPA1 gene polymorphisms with pain sensitivity: a protocol for an adaptive recall by genotype study

N. Timpson, K. Phillips, A. Pickering, 2022, BMC medical genomics.

Decoupling of Sleep-Dependent Cortical and Hippocampal Interactions in a Neurodevelopmental Model of Schizophrenia

Mark D. Tricklebank, Keith G. Phillips, Dale M. Edgar, 2012, Neuron.

Laminar analysis of the role of GluR1 in experience-dependent and synaptic depression in barrel cortex

K. Fox, N. Hardingham, N. Wright, 2008, Nature Neuroscience.

GABAB receptor modulators potentiate baclofen‐induced depression of dopamine neuron activity in the rat ventral tegmental area

E. Sher, K. Phillips, Ying Chen, 2005 .

Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy

A. Blockeel, M. O'Neill, F. Gastambide, 2017, Alzheimer's Research & Therapy.

GABA(B) receptor modulators potentiate baclofen-induced depression of dopamine neuron activity in the rat ventral tegmental area.

E. Sher, K. Phillips, Ying Chen, 2005, British Journal of Pharmacology.

Modulation of the N13 component of the somatosensory evoked potentials in an experimental model of central sensitization in humans

A. Mouraux, L. Garcia-Larrea, Massimiliano Valeriani, 2021, Scientific Reports.

The nicotinic alpha 4 beta 2 receptor selective agonist, TC-2559, increases dopamine neuronal activity in the ventral tegmental area of rat midbrain slices.

E. Sher, K. Phillips, L. Broad, 2003, Neuropharmacology.

Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy

A. Blockeel, M. O'Neill, F. Gastambide, 2017, Alzheimer's Research & Therapy.

From structure to clinic: Design of a muscarinic M1 receptor agonist with the potential to treat Alzheimer’s disease

Stephen R. Morairty, Robert T. Smith, G. Dawson, 2021, Cell.

IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG)

A. Mouraux, R. Treede, I. Tracey, 2021, Trials.

Altered low-frequency brain rhythms precede changes in gamma power during tauopathy

Fabio R. Rodrigues, A. Saleem, S. Solomon, 2021, bioRxiv.

The test–retest reliability of large and small fiber nerve excitability testing with threshold tracking

A. Mouraux, R. Treede, A. Blockeel, 2023, Clinical neurophysiology practice.

Phenotypic characterization of nonsocial behavioral impairment in neurexin 1α knockout rats.

G. Gilmour, K. Phillips, Sally Loomis, 2015, Behavioral neuroscience.

Initiation and slow propagation of epileptiform activity from ventral to dorsal medial entorhinal cortex is constrained by an inhibitory gradient

Jonathan T. Brown, K. Phillips, A. Randall, 2018, The Journal of physiology.

Impaired speed encoding is associated with reduced grid cell periodicity in a mouse model of tauopathy

Keith G. Phillips, Jonathan T. Brown, Thomas Ridler, 2018, bioRxiv.

TaiNi: Maximizing research output whilst improving animals’ welfare in neurophysiology experiments

Esther Rodriguez-Villegas, Stuart A. Bowyer, Zhou Jiang, 2017, Scientific Reports.

The subtype-selective nicotinic acetylcholine receptor positive allosteric potentiator 2087101 differentially facilitates neurotransmission in the brain.

E. Sher, G. de Filippi, K. Phillips, 2010, European journal of pharmacology.

Partial agonists for α4β2 nicotinic receptors stimulate dopaminergic neuron firing with relatively enhanced maximal effects

K. Phillips, L. Broad, Ying Chen, 2012, British journal of pharmacology.

Trial by trial, machine learning approach identifies temporally discrete Aδ- and C-fibre mediated laser evoked potentials that predict pain behaviour in rats

A. Mouraux, J. Huxter, K. Phillips, 2021, bioRxiv.

IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NE

A. Mouraux, R. Treede, I. Tracey, 2022, Trials.